Kip Ludwig leads the Ludwig Laboratory at the University of Wisconsin, specializing in neuromodulation, bioelectronic medicine, and electroceutical devices. The lab’s primary focus is to develop minimally invasive, next-generation neuromodulation therapies to hack the nervous system, treat circuit dysfunction, and deliver biomolecules precisely to target areas. Ludwig previously served as the program director for Neural Engineering at the NIH. He co-led the Translational Devices Program at the NINDS, led NIH BRAIN Initiative programs to catalyze implantable academic and clinical devices, and led a trans-NIH planning team to develop the S.P.A.R.C. Program - stimulating advances in neuromodulation therapies for organ systems.

Pierre Gressens, MD, PhD, is the director of the NeuroDiderot Research Center (INSERM and Université de Paris) at the Robert Debré Hospital in Paris.